Unosi

• Klinički značajne interakcije opioidnih i neopioidnih analgetika (Clinically important drug interactions of opioid and non-opioid analgetics) (2018)

  S. Vezmar Kovačević, K. Vučićević, V. Topić-Vučenović, Z. Rajkovača, B. Miljković, Klinički značajne interakcije opioidnih i neopioidnih analgetika (Clinically important drug interactions of opioid and non-opioid analgetics), Arhiv za farmaciju, Vol. 68, No. 6, pp. 1071 - 1083, 2018

• Izazovi i stavovi o doziranju radioaktivnog joda u terapiji benignih oboljenja štitne žlijezde (2018-04)

  V. Topić Vučenović, Z. Rajkovača, S. Vezmar Kovačević, B. Miljković, K. Vučićević, Izazovi i stavovi o doziranju radioaktivnog joda u terapiji benignih oboljenja štitne žlijezde, Arhiv za farmaciju, Vol. 67, pp. 333 - 344, Apr, 2018

• Investigation of factors influencing radioiodine (131I) biokinetics in patients with benign thyroid disease using nonlinear mixed effects approach (2018-05)

  V. Topić Vučenović, Z. Rajkovača, D. Jelić, D. Stanimirović, G. Vuleta, B. Miljković, K. Vučićević, Investigation of factors influencing radioiodine (131I) biokinetics in patients with benign thyroid disease using nonlinear mixed effects approach, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, Vol. 74, No. 8, pp. 1037 - 1045, May, 2018

• Klinički značajne interakcije opioidnih i neopioidnih analgetika (Clinically important drug interactions of opioid and non-opioid analgetics) (2018-12)

  S. Vezmar Kovačević, K. Vučićević, V. Topić Vučenović, Z. Rajkovača, B. Miljković, Klinički značajne interakcije opioidnih i neopioidnih analgetika (Clinically important drug interactions of opioid and non-opioid analgetics), Arhiv za farmaciju, Vol. 68, No. 6, pp. 1071 - 1083, Dec, 2018

• Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients (2020)

  T. Kovačević, B. Miljkovic, P. Kovačević, S. Dragic, D. Momcicevic, S. Avram, M. Jovanovic, K. Vucicevic, Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients, JOURNAL OF CRITICAL CARE, pp. 116 - 121, 2020

• Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients (2020-06)

  T. Kovačević, B. Miljkovic, P. Kovačević, S. Dragić, D. Momčičević, S. Avrama, M. Jovanovic, K. Vucicevic, Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients, JOURNAL OF CRITICAL CARE, Vol. 55, pp. 116 - 121, Jun, 2020

• Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice (2021-08)

  M. Roganović, A. Homšek, M. Jovanović, V. Topić Vučenović, M. Ćulafić, B. Miljković, K. Vučićević, Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice, Arhiv za farmaciju, Vol. 71, No. 4, pp. 336 - 353, Aug, 2021

• Nonlinear mixed effects modelling approach for investigation of 131I in patients with benign thyroid disease (2017)

  V. Topić Vučenović, k. vučičević, z. rajkovača, d. stanimirović, D. Jelić, g. vuleta, b. miljković, Nonlinear mixed effects modelling approach for investigation of 131I in patients with benign thyroid disease, 2017

• Nonlinear mixed effects modelling approach for investigation of 131I kinetics in patients with benign thyroid disease (2017-06)

  V. Topić Vučenović, K. Vučićević, Z. Rajkovača, D. Stanimirović, G. Vuleta, D. Jelić, B. Miljković, Nonlinear mixed effects modelling approach for investigation of 131I kinetics in patients with benign thyroid disease, Jun, 2017

• Investigation of influence of anti-thyroid drug discontinuation time on 131I biokinetics in patients with benign thyroid disease (2017-10)

  V. Topić, K. Vučićević, Z. Rajkovača, D. Stanimirović, G. Vuleta, D. Jelić, B. Miljković, Investigation of influence of anti-thyroid drug discontinuation time on 131I biokinetics in patients with benign thyroid disease, Eur J Nucl Med Mol Imaging. 2017; 44 (Suppl 2), pp. S809 - S809, Oct, 2017

• Investigation of the influence of functional thyroide volumen on the probability of 131 I therapy outcome in patients with benign thyroide disease (2018)

  V. Topić Vučenović, D. Jelić, Z. Rajkovača, S. Miljković, K. Vučićević, Investigation of the influence of functional thyroide volumen on the probability of 131 I therapy outcome in patients with benign thyroide disease, 2018

• Prediction of the radioiodine therapy outcomes in patients with benign thyroid disease based on pre-therapeutic dosimetry (2018-09)

  V. Topić Vučenović, D. Jelić, Z. Rajkovača, B. Miljković, K. Vučićević, Prediction of the radioiodine therapy outcomes in patients with benign thyroid disease based on pre-therapeutic dosimetry, Kongres nuklearne medicine Srbije sa međunarodnim učešćem 2018, Program i zbornik sažetaka, pp. 135 - 135, Sep, 2018

• Population exposure-response model of 131I in patients with benign thyroid disease (2021-10)

  V. Topić Vučenović, Z. Rajkovača, D. Jelić, D. Stanimirović, M. Mikov, B. Miljković, K. Vučićević, Population exposure-response model of 131I in patients with benign thyroid disease, EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, Vol. 165, pp. 105942 - 105942, Oct, 2021

• The influence of biologically effective dose (BED) on the 131I therapy response in patients with benign thyroid disease – nonlinear mixed effect modelling approach (2021-01)

  V. Topić Vučenović, Z. Rajkovača, D. Jelić, D. Stanimirović, M. Mikov, B. Miljković, K. Vučićević, The influence of biologically effective dose (BED) on the 131I therapy response in patients with benign thyroid disease – nonlinear mixed effect modelling approach, https://www.paganz.org/abstracts/the-influence-of-biologically-effective-dose-bed-on-the-131i-therapy-response-in-patients-with-benign-thyroid-disease-nonlinear-mixed-effect-modelling-approach/, Jan, 2021